Jian‐Gao Fan

6.3k total citations · 3 hit papers
86 papers, 2.8k citations indexed

About

Jian‐Gao Fan is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jian‐Gao Fan has authored 86 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Epidemiology, 23 papers in Hepatology and 22 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jian‐Gao Fan's work include Liver Disease Diagnosis and Treatment (62 papers), Diet, Metabolism, and Disease (16 papers) and Hepatitis B Virus Studies (10 papers). Jian‐Gao Fan is often cited by papers focused on Liver Disease Diagnosis and Treatment (62 papers), Diet, Metabolism, and Disease (16 papers) and Hepatitis B Virus Studies (10 papers). Jian‐Gao Fan collaborates with scholars based in China, United States and Australia. Jian‐Gao Fan's co-authors include Yuanwen Chen, Qin Pan, Da Zhou, Wenjin Ding, Feng‐Zhi Xin, Rui-Nan Zhang, Rui‐Xu Yang, Haixia Cao, Guangyu Chen and Feng Shen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Jian‐Gao Fan

81 papers receiving 2.8k citations

Hit Papers

Sodium butyrate attenuates high-fat diet-induced steatohe... 2017 2026 2020 2023 2017 2017 2024 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian‐Gao Fan China 27 1.5k 953 504 503 475 86 2.8k
Koichiro Wada Japan 28 2.0k 1.3× 635 0.7× 608 1.2× 432 0.9× 760 1.6× 146 3.3k
Kalpana Luthra India 30 851 0.6× 491 0.5× 713 1.4× 595 1.2× 79 0.2× 165 3.1k
Xilong Li United States 30 518 0.3× 499 0.5× 331 0.7× 255 0.5× 186 0.4× 94 2.9k
Rodrig Marculescu Austria 31 537 0.4× 1.0k 1.1× 231 0.5× 311 0.6× 180 0.4× 157 3.2k
Rodolphe Anty France 36 3.0k 2.0× 857 0.9× 786 1.6× 865 1.7× 1.4k 2.9× 112 5.1k
Carol Ho-Yan Fong Hong Kong 24 894 0.6× 1.2k 1.3× 421 0.8× 489 1.0× 35 0.1× 64 3.1k
Călin D. Popa Netherlands 26 508 0.3× 632 0.7× 104 0.2× 204 0.4× 112 0.2× 59 3.3k
В. Т. Ивашкин Russia 29 837 0.5× 587 0.6× 233 0.5× 263 0.5× 439 0.9× 293 2.6k
Raja Affendi Raja Ali Malaysia 23 606 0.4× 1.2k 1.2× 96 0.2× 344 0.7× 67 0.1× 95 2.7k
Marialena Mouzaki United States 24 2.7k 1.8× 932 1.0× 1.2k 2.4× 935 1.9× 856 1.8× 98 4.0k

Countries citing papers authored by Jian‐Gao Fan

Since Specialization
Citations

This map shows the geographic impact of Jian‐Gao Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐Gao Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐Gao Fan more than expected).

Fields of papers citing papers by Jian‐Gao Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian‐Gao Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐Gao Fan. The network helps show where Jian‐Gao Fan may publish in the future.

Co-authorship network of co-authors of Jian‐Gao Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Jian‐Gao Fan. A scholar is included among the top collaborators of Jian‐Gao Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian‐Gao Fan. Jian‐Gao Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Lillian, Lili Liang, Yi Yang, et al.. (2025). Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease. mSystems. 10(4). e0114824–e0114824. 7 indexed citations
2.
Zeng, Jing, Yuancheng Li, Jing Wang, et al.. (2024). Joint effects of sleep disturbance and renal function impairment on incident new‐onset severe metabolic dysfunction‐associated steatotic liver disease. Diabetes Obesity and Metabolism. 26(10). 4724–4733.
3.
Zeng, Jing, Jian‐Gao Fan, & Sven Francque. (2024). Therapeutic management of metabolic dysfunction associated steatotic liver disease. United European Gastroenterology Journal. 12(2). 177–186. 54 indexed citations breakdown →
4.
Chan, Wah‐Kheong, George Boon‐Bee Goh, Vincent Wai‐Sun Wong, et al.. (2023). Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP‐Asia study. Journal of Viral Hepatitis. 30(4). 319–326. 3 indexed citations
5.
Zhang, Jianbin, et al.. (2023). Therapeutic Effect of Prolyl Endopeptidase Inhibitor in High-fat Diet-induced Metabolic Dysfunction-associated Fatty Liver Disease. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 3 indexed citations
6.
Zeng, Jing, Jian‐Gao Fan, & Huiping Zhou. (2023). Bile acid-mediated signaling in cholestatic liver diseases. Cell & Bioscience. 13(1). 77–77. 41 indexed citations
7.
Zeng, Jing, Jin Qian, Jing Yang, et al.. (2023). Prevalence and incidence of MAFLD and associated anthropometric parameters among prepubertal children of the Shanghai Birth Cohort. Hepatology International. 17(6). 1416–1428. 9 indexed citations
8.
Zeng, Jing, et al.. (2021). The burden and sexual dimorphism with nonalcoholic fatty liver disease in Asian children: A systematic review and meta‐analysis. Liver International. 42(9). 1969–1980. 14 indexed citations
9.
Fan, Jian‐Gao, et al.. (2021). Peripheral immune cells in NAFLD patients: A spyhole to disease progression. EBioMedicine. 75. 103768–103768. 17 indexed citations
10.
Ren, Tianyi & Jian‐Gao Fan. (2021). What are the clinical settings and outcomes of lean NAFLD?. Nature Reviews Gastroenterology & Hepatology. 18(5). 289–290. 20 indexed citations
11.
Zhang, Jianbin, Daixi Jiang, Mengting Li, et al.. (2020). Chronic hepatitis B and non‐alcoholic fatty liver disease: Conspirators or competitors?. Liver International. 40(3). 496–508. 48 indexed citations
12.
Zhou, Da, Yuanwen Chen, Zehua Zhao, et al.. (2018). Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression. Experimental & Molecular Medicine. 50(12). 1–12. 182 indexed citations
13.
Liu, Xiaolin, Qin Pan, Rui-Nan Zhang, et al.. (2016). Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population. World Journal of Gastroenterology. 22(44). 9844–9844. 85 indexed citations
14.
Yang, Liping, et al.. (2014). Comparison of blood sugar and glycosylated hemoglobin in type 2 diabeticpatients of Chinese provinces at different altitudes.. Biomedical Research-tokyo. 25(3). 0.
15.
Shen, Feng, Junping Shi, Liang Xu, et al.. (2014). [A multi-center clinical study of a novel controlled attenuation parameter for assessment of fatty liver].. PubMed. 22(12). 926–31. 4 indexed citations
16.
Duan, Xiaoyan, Qin Pan, Shiyan Yan, et al.. (2014). High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma. BMC Gastroenterology. 14(1). 195–195. 24 indexed citations
17.
Shen, Feng, et al.. (2011). An epidemiologicai investigation of irritable bowel syndrome in Shanghai Songjiang communities. Zhonghua xiaohua zazhi. 31(10). 663–668. 4 indexed citations
18.
Shi, Junping, et al.. (2011). Metabolic syndrome and severity of fibrosis in patients with chronic viral hepatitis B infection or non-alcoholic fatty liver disease. African Journal of Microbiology Research. 5(5). 481–485. 2 indexed citations
20.
Fan, Jian‐Gao, et al.. (2001). Overexpression of hepatic plasminogen activator inhibitor type 1 mRNA in rabbits with fatty liver. World Journal of Gastroenterology. 7(5). 710–710. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026